645 related articles for article (PubMed ID: 12230594)
1. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
3. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
Shrivastava R; Pechadre JC; John GW
Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
10. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Edvinsson L; Rapoport AM; Lipton RB; Spierings EL; Diener HC; Burstein R; Loupe PS; Ma Y; Yang R; Silberstein SD
Lancet Neurol; 2015 Nov; 14(11):1091-100. PubMed ID: 26432181
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
[TBL] [Abstract][Full Text] [Related]
13. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of feverfew as prophylactic treatment of migraine.
Johnson ES; Kadam NP; Hylands DM; Hylands PJ
Br Med J (Clin Res Ed); 1985 Aug; 291(6495):569-73. PubMed ID: 3929876
[TBL] [Abstract][Full Text] [Related]
15. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
17. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study.
Pfaffenrath V; Wessely P; Meyer C; Isler HR; Evers S; Grotemeyer KH; Taneri Z; Soyka D; Göbel H; Fischer M
Cephalalgia; 1996 Oct; 16(6):436-40. PubMed ID: 8902254
[TBL] [Abstract][Full Text] [Related]
18. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Klapper J
Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.
Ernst E; Pittler MH
Public Health Nutr; 2000 Dec; 3(4A):509-14. PubMed ID: 11276299
[TBL] [Abstract][Full Text] [Related]
20. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
Grossman W; Schmidramsl H
Altern Med Rev; 2001 Jun; 6(3):303-10. PubMed ID: 11410074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
